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Abstract
Background: Despite some problems related to accuracy and applicability of malaria rapid diagnostic tests (RDTs),
they are currently the best option in areas with limited laboratory services for improving case management
through parasitological diagnosis and reducing over-treatment. This study was conducted in areas with declining
malaria burden to assess; 1) the accuracy of RDTs when used at different community settings, 2) the impact of
using RDTs on anti-malarial dispensing by community-owned resource persons (CORPs) and 3) adherence of
CORPs to treatment guidelines by providing treatment based on RDT results.
Methods: Data were obtained from: 1) a longitudinal study of passive case detection of fevers using CORPs in six
villages in Korogwe; and 2) cross-sectional surveys (CSS) in six villages of Korogwe and Muheza districts, north-
eastern, Tanzania. Performance of RDTs was compared with microscopy as a gold standard, and factors affecting
their accuracy were explored using a multivariate logistic regression model.
Results: Overall sensitivity and specificity of RDTs in the longitudinal study (of 23,793 febrile cases; 18,154 with
microscopy and RDTs results) were 88.6% and 88.2%, respectively. In the CSS, the sensitivity was significantly lower
(63.4%; c
2 = 367.7, p < 0.001), while the specificity was significantly higher (94.3%; c
2 = 143.1, p < 0.001) when
compared to the longitudinal study. As determinants of sensitivity of RDTs in both studies, parasite density of <
200 asexual parasites/μl was significantly associated with high risk of false negative RDTs (OR≥16.60, p < 0.001),
while the risk of false negative test was significantly lower among cases with fever (axillary temperature ≥37.5°C)
(OR ≤ 0.63, p ≤ 0.027). The risk of false positive RDT (as a determinant of specificity) was significantly higher in
cases with fever compared to afebrile cases (OR≥2.40, p < 0.001). Using RDTs reduced anti-malarials dispensing
from 98.9% to 32.1% in cases aged ≥5 years.
Conclusion: Although RDTs had low sensitivity and specificity, which varied widely depending on fever and
parasite density, using RDTs reduced over-treatment with anti-malarials significantly. Thus, with declining malaria
prevalence, RDTs will potentially identify majority of febrile cases with parasites and lead to improved management
of malaria and non-malaria fevers.
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Prompt and correct diagnosis is important for effective
management of malaria cases in order to reduce mor-
bidity and mortality caused by delayed or poor manage-
ment of patients particularly among under-fives and
pregnant women. Malaria diagnosis has for a long time,
and particularly at community level, depended on clini-
cal diagnosis (based on patients’ history and symptoms),
which has low specificity leading to over-diagnosis and
over-treatment [1]. Thus, reliable diagnostic services for
malaria are critical in order to reduce wastage of costly
drugs, e.g. artemisinin combination therapy (ACT), and
reduce drug selection pressure. The declining burden of
malaria in some endemic countries [2,3], increases the
risks of over-diagnosis and over-treatment even further.
Microscopic examination of Giemsa-stained blood
smears confirms the presence of malaria parasites and
remains the gold standard for malaria diagnosis despite
its technical challenges and demand for trained person-
nel. However, most peripheral health facilities in malaria
endemic countries lack the capacity to carry out parasi-
tological diagnosis of malaria by microscopy [4-6]. In
Tanzania, some hospitals which are commonly located
in urban and few health facilities in rural areas have
laboratories which are appropriately equipped and
staffed to perform good quality malaria diagnosis by
microscopy [7,8]. Following the recent recommendations
of the World Health Organization (WHO) to adopt uni-
versal testing to confirm presence of malaria parasites
(in patients of all age groups) before treatment with
ACT, malaria rapid diagnostic tests (RDTs) are increas-
i n g l yc o n s i d e r e dt ob et h eb e s ta l t e r n a t i v ei na r e a s
where high quality microscopy cannot be performed [9].
The RDTs utilize immuno-chromatographic methods
to detect parasite specific antigens in lysed blood and
the widely used tests detect either species-specific Plas-
modium falciparum histidine rich protein 2 (PfHRP-2),
Plasmodium lactate dehydrogenase (pLDH) or aldolase
[10-12]. RDTs based on HRP-2 only detect P. falci-
parum, those based on pLDH and aldolase can detect P.
falciparum and other species of human malaria [11],
while some RDTs combine both HRP-2 and pLDH or
HRP-2 and aldolase to enhance their accuracy for detec-
tion of all four species of malaria parasite that infect
humans (P. falciparum, Plasmodium vivax, Plasmodium
ovale and Plasmodium malariae) in mixed or mono-
infections [13]. Currently, four brands of RDTs are
registered by the Tanzania Food and Drug Authority
(TFDA) and they include Paracheck Pf
® (Orchid Biome-
dical Systems - Mumbai, India), ParaHIT
®f (Span Diag-
nostics - Surat, India), ICT Malaria-Combo (ICT
Diagnostics, South Africa) and SD Bioline Malaria Ag
Pf/Pan (Standard Diagnostics Inc., India). Of these,
Paracheck and ParaHIT are HRP-2 tests for detection of
P. falciparum, while ICT Malaria-Combo and SD Bio-
line Malaria Ag Pf/Pan combine both HRP-2 and pLDH
and can, therefore, detect P. falciparum and other
human malaria parasite species.
Tanzania changed and implemented its malaria
treatment guidelines to replace sulphadoxine/pyri-
methamine (SP) with artemether/lumefantrine (ALu)
as first-line drug for treatment of uncomplicated
malaria in January 2007 [14]. The new guidelines
recommend that ALu should be prescribed to all feb-
rile children under five years of age suspected of
malaria (irrespective of laboratory results) while treat-
ment of individual aged ≥5 years of age has to be
based on laboratory confirmation of malaria parasites
(by microscopy or RDTs) except in health facilities
without diagnostic facilities. This strategy was consid-
ered to be cost-effective when using ALu and in areas
with moderate malaria transmission as shown by stu-
dies conducted in other malaria endemic areas [15,16].
Based on the current WHO recommendation of treat-
ing all patients after parasitological confirmation and
lack of laboratory capacity to carry out malaria diag-
nosis in most of the health facilities in Tanzania, the
Ministry of Health and Social Welfare through the
National Malaria Control Programme (NMCP) plans
to introduce a new malaria diagnostic policy in the
country aiming at using RDTs in places without facil-
ities for microscopy.
Currently, the NMCP in Tanzania has embarked on
operational research in order to identify key issues
which need to be addressed before, during and after
deployment of RDTs including choice and cost of
RDTs, setting up systems for quality assurance and
others such as issues related to procurement of the tests
[1]. Although RDTs require minimal skills and are easy
to read, which allow them to be used by moderately
trained health workers, their accuracy (sensitivity and
specificity), storage under field condition and application
for treatment of malaria remain a challenge
[11,12,17-21]. This study was conducted in an area with
declining burden of malaria to assess; 1) the accuracy of
RDTs when used at different community settings; 2) the
impact of RDTs on anti-malarial dispensing when used
by village helpers known as community-owned resource
persons (CORPs); and 3) adherence of CORPs to treat-
ment guidelines by treating attended cases based on
RDT results. Two different community study set-ups
were used; a longitudinal study using CORPs to pas-
sively monitor febrile illness, and cross-sectional surveys
(CSS) to monitor the declining burden of malaria in
areas, which were until recently holo/hyper-endemic to
malaria in north-eastern Tanzania.
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Study site and design
Data on malaria diagnosis performed using RDTs and
related information were obtained from two ongoing stu-
dies in six villages in Korogwe and four in Muheza dis-
tricts, in Tanga region, north-eastern Tanzania. The first
study was a longitudinal follow-up to passively detect
fever episodes using CORPs in the villages of Kwama-
simba, Mkokola, Kwamhanya, Magundi, Kwashemshi
and Mg’anza in Korogwe district and covered a period of
4.5 years from January 2006 to June 2010. The six villages
in Korogwe are under the demographic and health sur-
veillance system (DHSS) which together with CORPs
activities allow longitudinal follow-up of patients treated
at by CORPs in these communities. Two of the six vil-
lages in Korogwe district (Kwamasimba and Mkokola)
have been involved in different studies on immuno-epi-
demiology of malaria since 2003 and four more villages
(Kwamhanya, Magundi, Kwashemshi and Mg’aza) were
enrolled in similar studies in 2005. Detailed description
of these villages has been published previously [22,23].
The second study involved CSS conducted in six villages
between May 2007 and June 2010 including the two vil-
lages in Korogwe (Kwamasimba and Mkokola which also
participated in the longitudinal study) and four in
Muheza district which participated in different studies
(Magoda and Mamboleo from 1992, Mpapayu from 1997
[24,25] and Mgome which was enrolled in other studies
in 2001 [26,27]). In these areas, malaria burden has
declined in recent years as reported by Mmbando et al
[28] and Ishengoma et al (unpublished data).
Data collection methods
Longitudinal study
Cases presenting to CORPs with history of fever within
48 hours before the visit had history taken and clinical
presentation assessed. Axillary temperature was mea-
sured from all patients using a digital thermometer to
obtain fever at presentation, which was defined as axil-
lary temperature ≥37.5°C. Recruitment and initial train-
ing of CORPs was conducted as previously reported
[22,28]. One of the key elements of the training given to
CORPs was instructions on how to identify patients to
treat and those who needed referral to the nearby health
facility. Before introduction of ALu and RDTs in Febru-
ary 2007, CORPs were further trained on how to use
modified standard operating procedures (SOPs) written
in Kiswahili (the Tanzanian national language) with sim-
ple guidelines on how to perform RDTs for malaria
parasite detection, interpret the results and administer
treatment to malaria patients with ALu.
The longitudinal study has been divided into pre-RDT
(from January 2006 to January 2007) and post-RDT per-
iods (February 2007 to June 2010). During the pre-RDT
period, all patients with history of fever or fever at pre-
sentation were treated with SP. Thick and thin blood
smears were prepared from finger prick blood samples
for malaria diagnosis by microscopy that was performed
later in the laboratory. In the post-RDT period, thick
and thin blood smears were also collected as above and
RDTs for malaria diagnosis was performed by CORPs.
According to the SOPs, all children below five years of
age (with history of fever or fever at presentation) were
supposed to be treated with ALu regardless of RDT
results while those aged ≥5 years were only treated with
ALu if they had positive RDTs. Children and infants
weighing less than 5Kg were referred to the nearest
health facility for treatment. Routine supervision was
conducted weekly during both periods by a medical doc-
tor or a trained assistant medical officer and a labora-
tory technician. During the supervisory visits, general
performance of CORPs was assessed and on-spot train-
ing support provided. Blood smears prepared by CORPs
were collected during weekly supervision, and brought
to the laboratory for microscopic examination by trained
laboratory technicians. The results of microscopic exam-
ination of blood smears were given back to CORPs dur-
ing the next supervision and were used for treatment of
cases not given anti-malarials due to negative RDT
results.
Cross-sectional surreys (CSS)
Five malariometric surveys were conducted either during
short (November/December) or long (April/June) rainy
seasons from May 2007 to June 2010. About 250 study
participants were randomly selected from each of the
study villages with the aim of recruiting 120 children up
to five years of age (20 in each age band of one year,
from 0 - 5.9 years), 100 children from six to 15.9 years
(10 from each age band of two years) and 30 from 16 to
19.9 years (15 individuals from each of the age bands of
16 - 17.9 and 18-19.9 years). Each recruited person was
examined by a medical doctor and axillary temperature
was measured using a digital thermometer. Measured
fever (fever at presentation) was defined as axillary tem-
perature ≥37.5°C. Blood samples were collected from
each study participant by venous bleeding or finger
prick by trained laboratory technicians/research nurses
for parasitological examination and other laboratory
analyses. Blood smears for detection of malaria parasites
were prepared by trained laboratory technicians, dried
in the field and later brought to the laboratory for
further processing. Detection of malaria parasites by
RDTs was performed on fresh samples and participants
with fever or other malaria related symptoms, and posi-
tive RDTs results were treated using ALu and paraceta-
mol. Testing by RDTs was done by trained laboratory
technicians/research scientists according to manufac-
turers’ instructions.
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In the laboratory, blood smears were stained using 10%
Giemsa solution for 30 minutes and examined under
high power objective. In positive smears, asexual and
sexual parasites were counted against 200 and 500 white
blood cells (WBCs), respectively. Parasite density was
obtained by multiplying the parasite counts by 40 for
asexual and 16 for sexual parasites (assuming each
micro litre of blood contained 8000 WBCs). A smear
was declared negative after examining 200 high power
fields. For quality control purposes, each blood smear
was examined by two technicians blinded of the patient
status and RDT results. The final parasite density was
taken as the average of the counts of the two techni-
cians if their results did not differ by more than 50% for
blood smears with ≥400 asexual parasites/μl of blood. In
blood smears with < 400 asexual parasites/μl, any counts
of each of the two technicians was accepted and used to
calculate the average parasite density. Blood smears with
discordant results were re-examined by a third techni-
cian and the results of any two technicians was accepted
as explained above. Further discordant smears were
resolved by a team of three technicians who re-exam-
ined such smears at the same time.
Two different types of HRP-2 based RDTs were used
in the two studies; ParacheckPf
® (Orchid Biomedical
Systems - Mumbai, India) was used in the longitudinal
s t u d yf r o mN o v e m b e r2 0 0 7t oJ u n e2 0 0 9w h i l eP a r a -
HIT
®f (Span Diagnostics - Surat, India) was used from
February to October 2007 and July 2009 to June 2010.
In the CSS, Paracheck was used in November 2007 and
May 2008 while ParaHIT was used in May 2007, 2009
and 2010. For quality control (QC) purposes, all RDTs
were stored at 4 - 8°C in a special air-conditioned room,
which was monitored twice a day during working days
and once on week-ends and public holidays. To avoid
keeping large number of RDT kits in the villages with-
out appropriate storage rooms, small batches were deliv-
ered to the CORPs during weekly supervision. The
RDTs delivered to CORPs were stored at ambient tem-
perature (temperature ranged from 25 to 34°C) and the
duration of storage in the field was kept at less than two
weeks.
Ethical considerations
The studies which contributed data used in this paper
were approved by the Medical Research Coordination
Committee of the National Institute for Medical
Research. Verbal and written informed consent was
sought from patients or parents/guardians in case of
children. For both studies, village meetings were held to
explain and discuss the study plans with community
members. In case of CSS, feedback and results of the
previous surveys were communicated back to the
communities through the above meetings together with
a written report.
Data analysis
Data management was done using Microsoft Access
database with double entry, validation and cleaning; fol-
lowed by analysis using STATA version 10 (STATA
Corp Inc., TX, USA) and R - Statistical Software [29].
Sensitivity and specificity of RDTs were calculated by
comparing RDT results with microscopy as a gold stan-
dard. Predictors of a risk of obtaining false negative
RDTs results as determinants of sensitivity of RDTs
were calculated using a multivariate logistic regression
model adjusting for age of study participants (under-
fives vs. cases aged ≥5 years old), fever status at presen-
tation (fever was defined as axillary temperature ≥37.5°
C), parasite density and year of study as a measure of
malaria parasite prevalence. For predictors of a risk of
obtaining false positive RDT results as determinants of
s p e c i f i c i t yo fR D T s ,a d j u s t m e n tw a sd o n ef o ra g eo f
study participants, fever status and year of study. Since
the villages included in this study had different malaria
transmission intensity, which depends on altitude [23],
adjustment was made in the regression model to
account for the differences in transmission intensity by
grouping the villages into those from either low or high
transmission areas. The villages of Kwamasimba, Kwam-
hanya and Magundi (located in the highlands) were
categorized into low transmission while Kwashemshi,
Mkokola and Mng’aza in Korogwe, and Magoda, Mam-
boleo, Mgome and Mpapayu in Muheza district (located
in the lowlands) were considered to be in high transmis-
sion areas. P-value < 0.05 was considered to be
significant.
Results
Baseline characteristics
In the longitudinal study, a total of 23,793 febrile cases
were attended by CORPs between January 2006 and
June 2010. A majority of these (18,217, 76.6%) were
attended during the post-RDT period (February 2007 -
June 2010) while 5,576 (23.3%) cases were attended in
the pre-RDT period (January 2006 - January 2007).
Baseline characteristics of the cases attended by CORPs
are shown in table 1. Most of the cases attended in the
entire period of the study (> 77.6%) were aged over 5
years. The mean age of attended cases was significantly
higher during the pre-RDT period compared to the
post-RDT period (t = 12.3, p < 0.001). Almost all
patients (99.0% and 99.4% during the pre- and post-
RDTs periods, respectively) had a history of fever
(within 48 hours before reporting to the CORPs) but
only 31.9% (30.9%, and 32.2% during the pre and post-
RDTs periods, respectively) had fever (≥37.5°C) at
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similar in the two periods while geometric mean para-
site density were significantly higher during the post-
RDT compared to the pre-RDT period (t-test = 4.9, p <
0.001) (Table 1). Out of 18,158 patients tested for
malaria parasites using RDTs, only 27.8% were found to
be positive (23.0% in children below 5 years of age and
29.2% in those aged ≥5 years).
Five CSS were conducted in a period of 4 years (from
May 2007 to May 2010) and all were done during the
long rainy season in May except one survey, which was
conducted during the sort rainy season in November/
December 2007. In total, 5,759 individuals aged 0-20
years (mean = 8.1, SD = 5.1 years) participated in the
surveys and most of them (64.7%) were aged between 5
and 20 years (Table 1). Individuals with history of fever
(within 48 hours) accounted for 13.5% while only 3.1%
had fever at presentation (≥37.5°C). Overall malaria
parasite prevalence by microscopy (in all age groups)
was 18.2% (ranged from 29.6% in 2008 to 10.4% in
2010) and 16.2% were positive by RDTs (range: 28.9% in
2008 to 6.4% in 2010). Compared to the longitudinal
study, participants enrolled in the CSS had lower geo-
metric mean parasite density (Table 1). In both studies,
cases with fever (≥3 7 . 5 ° C )w e r em o r el i k e l yt oh a v e
malaria parasites compared to those without fever, after
adjusting for age, year of study and level of transmission
intensity (in the longitudinal study, adjusted OR = 3.00,
p < 0.001 and in the CSS, adjusted OR = 4.16, p <
0.001).
Sensitivity and specificity of RDTs
In the longitudinal study, 8,848(48.6%) cases were tested
with Paracheck and the rest (51.4%) were tested with
ParaHIT while in the CSS, 2,664 (46.3%) individuals
were tested with Parachecka n d3 , 1 9 5( 5 3 . 7 % )w e r e
tested with ParaHIT. The number of cases with false
positive RDT results (with negative blood smear results
by microscopy) in the longitudinal study was higher
(1,695, 9.3%) compared to those with false negative
RDTs (427, 2.4%). Paracheck had large number of cases
with false positive RDTs (1,008, 11.4%) compared to
ParaHIT (687, 7.4%) while the proportion of cases with
false negative results was similar for the two brands of
RDTs (2.2% for Paracheck and 2.5% for ParaHIT). In
the CSS, 268 (4.7%) individuals had false positive results
while 382 (6.6%) had false negative results. Among indi-
viduals tested with Paracheck in the CSS, 161(6.1%) had
false positive results by RDTs and 164(6.2%) had false
negative results while for ParaHIT, 107(3.5%) had false
positive and 218(7.0%) had false negative results corre-
sponding to the high specificity but low sensitivity of
ParaHIT observed in the cross-section surveys.
Using the results of microscopic examination of
Giemsa-stained blood smears as gold standard, the over-
all sensitivity of RDTs was significantly higher in the
longitudinal study (88.6%) compared to the CSS (63.4%,
c
2 = 367.7, p < 0.001). For both studies, the sensitivity
was higher in febrile patients irrespective of age group
(Table 2). Both RDT brands had similar sensitivity in
the longitudinal study (adjusted OR = 1.03, p = 0.896)
while in the CSS, ParaHIT (46.3%) had significantly
lower sensitivity compared to Paracheck (74.3%,
adjusted OR = 8.63, p < 0.001) after correcting for age
of individuals tested, fever, parasite density, parasite pre-
valence and transmission intensity (Table 3). In both
studies, the sensitivity of RDTs increased with parasite
density, ranging from a low 35.2% at < 200 asexual para-
sites/μl to 96.6% at parasite density ≥4001 asexual para-
sites/μl (Table 3 and Figure 1). Parasite density < 200
asexual parasites/μl was significantly associated with
high risk of false negative RDT results (adjusted
OR≥16.60, p < 0.001) while the risk of false negative test
was significantly lower among cases with fever (adjusted
OR ≤ 0.63, p ≤ 0.027) (Table 3). For both studies, the
sensitivity of RDTs decreased with decreasing malaria
Table 1 Baseline characteristics of participants enrolled in the longitudinal study and CSS in Korogwe and Muheza
districts
Variable Longitudinal study
(Pre-RDTs)
Longitudinal study
(Post-RDTs)
CSS
Number of cases sampled/attended 5576 18217 5759
Mean age in years (range) 26.2(0, 96.0) 22.2(0, 98.2) 8.1(0, 20.0)
Age group (< 5 years, %) 1065(19.1) 4275(23.5) 2033(35.3)
Sex- Male (%) 42.9 46.0 45.4
Cases with fever
(axillary temperature ≥37.5°C, %)
1720(30.9) 5866(32.2) 176(3.1)
Cases with BS positive (%) 1130(20.5) 3779(20.8) 1045(18.2)
Cases wtih RDT Positive (%) NA 5038(27.8) 931(16.2)
PfGMPD* (95% CI) 3589(3081,4180) 5479(5051,5944) 489(428,558)
CSS = cross-sectional surveys, % = percentage,°C = degree centigrade, BS = blood smears, RDTs = malaria rapid diagnostic tests, *PfGMPD = Plasmodium
falciparum geometric mean parasite density (asexual parasites/μl), 95% CI = 95% confidence interval, NA = Not applicable.
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the study (Table 3 and Figure 2). The effect of malaria
transmission intensity on the risk of false negative RDT
results varied across the years and geographical location
of the study villages with higher sensitivity during years
with high parasite prevalence in 2007 and 2008, and in
villages with relatively high malaria transmission in the
CSS only (Table 3).
The overall specificity of RDTs was significantly
higher in the CSS (94.3%) compared to the longitudinal
study (88.2%, c
2 = 143.1, p < 0.001) and in cases with-
out fever compared to those with fever (Table 2). The
Table 2 Sensitivity and specificity of RDTs in the longitudinal study and CSS in Korogwe and Muheza districts
Positive rate
Study type Category (n) Microscopy
(%, 95% CI)
RDTs
(%, 95% CI)
Sensitivity
(%, 95% CI)
Specificity
(%, 95% CI)
Longitudinal study Under-fives + fever (n = 2116) 27.8 (25.9-29.7) 31.9(29.9-33.9) 92.1(89.9-94.3) 91.3(89.9-92.7)
Under-fives, no fever(n = 2159) 12.1(10.7-13.5) 14.3(12.8-15.8) 85.4(81.1-89.7) 95.6(94.7-96.5)
Above 5 years + fever (n = 3750) 37.3(36.0-39.0) 48.6(47.0-50.2) 92.3(90.9-93.1) 77.5(75.8-79.8)
Above 5 years, no fever (n = 10186) 15.0(14.3-15.7) 22.1(21.3-22.9) 84.6(82.8-86.4) 89.0(88.2-89.6)
Overall (18213) 20.8(20.2-21.4) 27.8(27.1-28.5) 88.6(87.5-89.7) 88.2(87.7-88.7)
CSS Under-fives + fever (n = 83) 32.5(22.4-42.6) 41.0(30.4-51.6) 96.3(89.0-100.0) 85.7(76.5-94.9)
Under-fives, no fever(n = 1940) 8.0(6.8-9.2) 10.5(9.1-11.9) 66.7(59.3-74.1) 94.4(93.3-95.5)
Above 5 years + fever (n = 96) 40.9(31.1-50.7) 41.9(32.0-51.8) 89.5(79.8-99.2) 90.9(83.3-98.5)
Above 5 years, no fever (n = 3906) 22.6(21.3-23.9) 18.0(16.8-19.2) 60.5(57.1-63.9) 94.5(93.7-95.3)
Overall (n = 5759) 18.2(17.2-19.2) 16.2(15.2-17.2) 63.4(59.8-67.1) 94.3(93.6-95.0)
CSS = Cross-sectional surveys, RDT = malaria rapid diagnostic tests, % = percentage,°C = degree centigrade, 95% CI = 95% confidence interval.
Table 3 Predictors of a risk of obtaining a false negative RDT results among individuals with positive blood smears as
determinants of RDT sensitivity in the longitudinal study and CSS in Korogwe and Muheza districts
Longitudinal study CSS
Variable/covariate Sensitivity (%) Unadjusted
OR(p-value)
Adjusted
OR(p-value)
Sensitivity (%) Unadjusted
OR(p-value)
Adjusted
OR(p-value)
RDT type
Paracheck 1422/1616(88.0) reference reference 475/639(74.3) reference reference
Parahit 1919/2152(89.2) 0.89(0.259) 1.03(0.896) 188/406(46.3) 3.36(< 0.001) 8.63(< 0.001)
Age group
< 5 years 761/845(90.1) reference reference 130/184(70.7) reference reference
≥5 years 2580/2923(88.3) 1.20(0.148) 0.65(0.005) 533/861(61.9) 1.48(0.026) 0.98(0.682)
Fever (axillary temperature ≥37.5°C)
No fever 1514/1787(84.7) reference reference 596/969(61.5) reference reference
With fever 1826/1980(92.2) 0.47(< 0.001) 0.63(< 0.001) 60/65(92.3) 0.13(< 0.001) 0.32(0.027)
Pf Density(asexual parasites/μl)
≥4001 2274/2355(96.6) reference reference 167/187(89.3) reference reference
2001-4000 162/177(91.5) 2.60(0.001) 2.465(0.001) 54/59(91.5) 0.77(0.623) 0.84(0.752)
801-2000 232/262(88.6) 3.63(< 0.001) 3.73(< 0.001) 105/128(82.0) 1.83(0.067) 1.77(0.104)
201-800 359/429(83.7) 5.47(< 0.001) 5.21(< 0.001) 188/248(75.8) 2.66(< 0.001) 2.00(< 0.001)
< 200 314/545(57.6) 20.65(< 0.001) 21.17(< 0.001) 149/423(35.2) 15.36(< 0.001) 16.60(< 0.001)
Year*
2007 1912/2132(89.7) reference reference 147/201(74.1) reference reference
2008 1141/1272(89.7) 0.99(0.985) 1.19(0.510) 326/438(74.4) 0.98(0.936) 1.85(0.013)
2009 192/247(77.7) 2.45(< 0.001) 2.63(< 0.001) 122/246(49.6) 2.91(< 0.001) 0,72(0.198)
2010 96/117(82.1) 1.90(0.011) 3.91(< 0.001) 66/160(41.3) 4.08(< 0.001) 0.99(0.998)
Location**
Highland 1084/1199(90.4) reference reference 22/51(43.1) reference reference
Lowland 2257/2569(87.9) 1.20(0.026) 1.10(0.441) 641/994(64.5) 0.41(0.003) 0.19(< 0.001)
RDT = malaria rapid diagnostic tests, CSS = cross-sectional surveys, OR = odds ratio, Pf = Plasmodium falciparum.
*Year of study was used to represent malaria parasite prevalence in both studies.
**Geographical location of the village based on altitude indicating level of malaria transmission.
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Page 6 of 13risk of false positive RDT results was significantly lower
with ParaHIT compared to Paracheck (adjusted OR ≤
0.53, p < 0.001). For both studies, the specificity of
RDTs increased with decreasing malaria parasite preva-
lence (Table 4 and Figure 3). The risk of false positive
RDT results as determinants of specificity was signifi-
cantly higher in cases with fever compared to afebrile
cases (adjusted OR≥2.40, p < 0.001). Decreasing malaria
parasite prevalence had significantly lower risk of false
positive RDT results in the longitudinal study (OR ≤
0.57, p < 0.001) compared to the CSS where the risk
was significantly lower in 2010 only (OR = 0.38, p <
0.001) (Table 4).
Impact of prompt diagnosis using RDTs on malaria
treatment
All cases attended during the pre-RDTs period (5,576)
except two had blood smears taken and 5,513(98.9%)
had microscopic results, whereby 20.5% had malaria
parasites detected later in the laboratory by microscopy.
Information regarding treatment was available for 5,557
(99.7%) and 5,478 cases (98.6%; including 97.2% in
under-fives and 98.9% in cases aged ≥5 years) were trea-
ted with SP, which was the first-line drug for treatment
of uncomplicated malaria (Table 5). During the post-
RDTs period, which involved 18,217 cases, all except
four cases had blood smears results and 20.8% had
malaria parasites detected by microscopy (Table 5).
Results for both microscopy and RDTs were available
for 18,154 (99.7%) cases and 18,090(99.3%) had treat-
ment records. Treatment with ALu was given to 8,562
(47.3%), whereby 96.6% of the under-fives and 32.1% of
those aged ≥5 years were treated irrespective of RDT
results. Based on RDT results, only 4,893 (27.1% of all
cases tested with RDTs) were treated with positive
RDTs while 3,629 (20.1%) were treated with ALu despite
negative RDT results. Among patients treated with
negative RDTs in the different age groups, 3,154 (74.3%)
were under-fives and 475 (3.4%) were aged ≥5y e a r s
(Table 5). In the post-RDT period, only 28.6% of the
cases treated with ALu were detected later in the labora-
tory to be negative by microscopy compared to 78.5% of
the cases treated with SP in the pre-RDT period who
were later confirmed to have negative microscopy
results (Table 5).
Adherence to treatment guidelines by CORPs
During the pre-RDT period, 79 (1.4%) cases were not
treated with anti-malarials and two had no blood smears
taken while 19 (0.3%, including 11 under-fives) had
malaria parasites detected later in the laboratory by
microscopy. Six of the 11 under-fives were referred to
the nearest dispensary for treatment while the remaining
five (with geometric mean parasite density of 34,820
asexual parasites/μl) were not given a referral. Out of
the remaining eight cases (≥5 years old), who were not
treated by CORPs but had malaria parasites detected
later by microscopy, five were referred to the nearest
health facility for treatment, one had received SP treat-
ment (in the past two weeks) and the remaining two
(aged 9.3 and 36.0 years, with parasite density of 2,320
and 10,080 asexual parasites/μl, respectively) were not
given a referral by CORPs. Thus, only seven cases
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Figure 1 Overall sensitivity of RDTs by parasite density for
blood smear positive samples in the longitudinal study and
CSS in Korogwe and Muheza districts. Bars represent proportion
of cases with positive blood smear results by different categories of
parasite density, asexual parasites/μl (black bars = longitudinal study,
n = 3793; and grey bars = CSS, n = 1045); Solid line = sensitivity of
RDTs in the longitudinal study and dotted line = sensitivity of RDTs
in the cross-sectional surveys (CSS)
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Figure 2 Sensitivity of RDTs by malaria parasite prevalence
stratified by the year of study. Bars represent proportion of cases
with positive blood smear results by microscopy by year of study
from 2007 to 2010 (black bars = longitudinal study and grey bars =
cross-sectional surveys - CSS); Solid line = sensitivity of RDTs in the
longitudinal study and dotted line = sensitivity of RDTs in the cross-
sectional surveys (CSS)
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Page 7 of 13(0.13%) went without treatment and would, therefore,
remain at risk of developing severe disease in case they
did not return to CORPs to seek for treatment or visit a
health facility for further treatment but without a refer-
ral from CORPs.
Among children below five years of age attended dur-
ing the post-RDT period, 144 (3.4%) were not treated
with anti-malarials contrary to the guidelines, which
required that all under-fives be treated with ALu irre-
spective of RDT results, giving adherence to treatment
guidelines of 96.6%. For cases aged ≥5 years tested with
RDTs (n = 13,787), 108(0.8%) with positive RDT results
were not treated with ALu whereas 475(3.4%) with a
negative RDT were treated contrary to the guidelines
given to CORPs. Thus, 583(4.2%) cases were incorrectly
treated by CORPs and adherence to treatment guide-
lines in this group was 95.8%. For those cases aged ≥5
years who were treated despite negative RDT results,
only 38 (0.3%) had malaria parasites detected by micro-
scopic examination of blood smears with geometric
mean parasite density of 1,115 asexual parasites/μl
(range, 40-142,000 asexual parasites/μl).
Based on blood smear results by microscopy, 249
(1.4%) cases [including eight under-fives (with geometric
mean parasite density of 58,466 asexual parasites/μl;
range = 40 - 394,440) and 241 cases aged ≥5 years (with
geometric mean parasite density of 265; range = 40 -
160,400 asexual parasites/μl)] were neither treated with
ALu nor referred to the nearest health facility by
CORPs. Using a cut-off of parasite density of 5,000 asex-
ual parasites/μl, only 36(0.2%) cases [including 5(0.1%)
under-fives and 31(0.2%) aged ≥5 years] were not trea-
ted with anti-malarial drugs and thus put at risk of
Table 4 Predictors of a risk of obtaining false positive RDT results among individuals with negative blood smears as
determinants of RDT specificity in the longitudinal study and CSS in Korogwe and Muheza districts
Variable/covariate Longitudinal study CSS
Specificity (%) Unadjusted
OR(-value)
Adjusted
OR(p-value)
Specificity (%) Unadjusted
OR(-value)
Adjusted
OR(p-value)
RDT type
Paracheck 6216/7226(86.0) reference reference 1857/2018(92.0) reference reference
Parahit 6475/7164(90.4) 0.65(< 0.001) 0.48(< 0.001) 2580/2687(96.0) 0.40(< 0.001) 0.53(< 0.001)
Age group
< 5 years 3119/3441(93.6) reference reference 1738/1847(94.1) reference reference
≥5 years 9497/10979(86.5) 2.30(< 0.001) 2.86(< 0.001) 2699/2858(94.4) 0.93(0.625) 1.01(0.935)
Fever (axillary temperature ≥37.5°C)
No fever 9492/10555(90.1) reference reference 4309/4563(94.4) reference reference
With fever 3198/3856(82.9) 1.88(< 0.001) 2.40(< 0.001) 98/111(88.3) 2.25(0.007) 2.84(0.001)
Year*
2007 3707/4396(84.3) reference reference 917/977(93.9) reference reference
2008 3944/4678(84.3) 1.00(0.982) 0.57(< 0.001) 940/1041(90.3) 1.64(0.003) 0.97(0.850)
2009 3502/3753(93.3) 0.38(< 0.001) 0.28(< 0.001) 1230/1305(94.3) 0.93(0.693) 0.99(0.955)
2010 1537/1563(98.3) 0.09(< 0.001) 0.10(< 0.001) 1350/1382(97.7) 0.36(< 0.001) 0.38(< 0.001)
Location**
Highland 4642/5381(86.3) reference reference 1321/1340(98.6) reference reference
Lowland 8049/9009(89.3) 0.75(< 0.001) 0.74(< 0.001) 3116/3365(92.6) 5.55(< 0.001) 7.33(< 0.001)
RDT = Malaria rapid diagnostic tests, CSS = cross-sectional surveys, OR = odds ratio.
*Year of study was used to represent malaria parasite prevalence in both studies.
**Geographical location of the villages based on altitude indicating level of malaria transmission.
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Figure 3 Specificity of RDTs by malaria parasite prevalence
stratified by the year of study. Bars represent proportion of cases
with positive blood smear results by microscopy by year of study
from 2007 to 2010 (black bars = longitudinal study and grey bars =
cross-sectional surveys - CSS); Solid line = specificity of RDTs in the
longitudinal study and dotted line = specificity of RDTs in the cross-
sectional surveys (CSS)
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Page 8 of 13developing a severe disease in case they did not return
to CORPs or go to find treatment elsewhere.
Discussion
The WHO has recently recommended that treatment
with anti-malarial drugs should be given to patients
with malaria parasites confirmed by laboratory tests or
RDTs in areas lacking the capacity for detection of
malaria parasite by microscopy [9]. The Tanzanian Min-
istry of Health and Social Welfare, through the NMCP
plans to scale-up malaria diagnosis by introducing RDTs
to improve case management and reduce inappropriate
dispensing of ACT, which was introduced in the country
in early 2007 [14]. However, RDTs have, as also con-
firmed in the present study some technical and opera-
tional challenges including their accuracy and
implementation. The accuracy of RDTs which is com-
monly measured by their sensitivity and specificity
(when compared to microscopy as a gold standard) is
very critical to avoid denying anti-malarial drugs to
patients with malaria due to false negative results and
unnecessary dispensing of drugs by treating patients
with false positive RDTs. Furthermore, as recently
shown [18,30,31], syndromic treatment due to lack of
diagnostic facilities or non-adherence to RDT results,
reduces the motivation for health-care providers to
search and treat alternative causes of fever, and thus
perpetuating high drug pressure which might eventually
lead to parasite tolerance/resistance to ACT.
The findings of this study showed that both RDT
brands (Paracheck and ParaHIT) had low sensitivity but
relatively high specificity depending on fever status,
parasite density, malaria parasite prevalence and trans-
mission intensity. The overall sensitivity of RDTs was
significantly higher in the longitudinal study compared
to CSS and decreased with declining malaria parasite
prevalence in both studies corresponding to the
declining burden of malaria in the study areas as
recently shown by Mmbando et al. [28] and Ishengoma
et al (unpublished data). The low sensitivity observed in
the CSS might mainly be due to large number of cases
with low level parasitaemia, which was below the detec-
tion limits of RDTs giving rise to high rate of false nega-
tive results. The low sensitivity of RDTs observed in the
current studies was similar to what has been reported in
other field studies conducted in South-eastern Tanzania
[21,32] and other parts with similarly low malaria ende-
micity [33-35]. However, it was lower than the sensitiv-
ity reported in Kilombero and north-eastern Tanzania
before the recent decline in the burden of malaria
[31,36] and also other parts of Africa (including East
Africa, Kenya [37]and Uganda [37-39], and others
[15,40,41]).
Despite the differences in parasite density in the two
studies (longitudinal study and CSS) which increased
with decreasing parasite prevalence, the sensitivity of
RDTs was higher in febrile cases, and this was similar to
what has been reported in studies conducted elsewhere
in Africa [19,37,42]. Increasing parasite density with
declining malaria burden observed in the study villages
could be due small sample size in the recent years
which led to inflated geometric mean parasite density as
recently shown by other studies [28]. However, the geo-
metric mean parasite density observed in both studies
was lower than those reported in other studies using
similar RDTs based on HRP-2 detection [43] and this
could be the cause of relatively lower sensitivity
observed in these community studies. Although the sen-
sitivity of RDTs was higher in under-fives compared to
those aged ≥5 years, the difference was not statistically
significant after adjusting for other covariates. This is
different from the findings reported from Kilombero,
where the sensitivity of RDTs was significantly lower
among older patients [36].
Table 5 Prescription of anti-malarial drugs by CORPs to febrile patients based on presence or absence of RDT results
Type of
patients
Patients with
BS +ve (%)
Patients
treated (% )
Patients treated
with RDT
+ve(%)
Patients treated
with RDT
-ve (%)
Patients treated
with BS
+ve (%)
Patients treated
with BS
-ve (%)
Pre-RDTs
Total(5576) 1130(20.5) 5478(98.6) NA NA 1107(20.1)‡ 4319(78.5)
< 5 yrs(1065) 282(26.8) 1030(97.2) NA NA 260(24.8) † 750(71.6)
≥5 yrs(4511) 884(19.0) 4448(98.9) NA NA 838(18.8) § 3560(80.1)
Post-RDTs
Total(18217) 3779(20.8) 8562(47.3) 4893(27.1)* 3629(20.1) 3383(18.7)# 5177(28.6)
< 5 yrs(4275) 850 (19.9) 4122(96.6) 951(22.4)** 3154(74.3) 826(19.4)## 3296(77.3)
≥5 yrs(13942) 2929 (21.0) 4440(32.1) 3942(28.6)*** 475(3.4) 2537(18.5)### 1881(13.6)
BS = blood smear, RDT = malaria rapid diagnostic test, +ve = positive, -ve = negative, NA = not applicable.
For cases with treatment records, ‡5494 in the pre-RDTs period (†1048 under-fives and §4446 aged≥5 years old) had smear results by microscopy; in the post-
RDT period, *18034 cases (**4247 under-fives and ***13787 with ≥5 years old) had RDT results while #18087 (##4266 under-fives and ###13821 aged ≥5 years
old) had blood smear results by microscopy; and these were used as denominators.
Ishengoma et al. Malaria Journal 2011, 10:176
http://www.malariajournal.com/content/10/1/176
Page 9 of 13Despite significantly higher specificity in the CSS com-
pared to the longitudinal study (which increased with
declining parasite prevalence), the specificity observed in
both studies was higher than what has been recently
reported with similar RDTs (based on HRP-2) in Malawi
[19]. False positive RDT results which lead to low speci-
ficity are commonly attributed to persistence of HRP-2
antigens mainly due to continued exposure to low level
infections leading to sub-patent parasitaemia, gametocy-
taemia or delayed clearance of HRP-2 after treatment
[12]. HRP-2 antigens remain in blood for over 30 days
after clearance of the parasites and persistence of HRP-2
has been shown to depend mainly on parasite density at
the initiation of treatment [43]. High specificity observed
in the CSS indicate that most of the cases without
malaria parasites residing in communities with low level
of parasite prevalence will most likely be correctly diag-
nosed by the RDTs. However, the low specificity of
RDTs among cases with fever in the longitudinal study
which resulted from large number of false positive
RDTs indicates that most of such cases were treated
with anti-malarials despite negative results by micro-
scopy leading to over-treatment and wastage of drugs.
Before introduction of RDTs, almost all cases attended
by CORPs were treated with SP based on presenting
symptoms leading to a significant level of over-treat-
ment, since only 20.1% of all cases treated with SP dur-
ing this period had malaria parasites confirmed by
microscopy. However, this approach was cost-effective
due to low cost of SP and was also safe since most of
the febrile cases (regardless of parasite infection status)
were promptly treated with anti-malarials thus reducing
the risks associated with severe malaria, which often
occurs when a patient is left without treatment. Despite
the observed low accuracy of RDTs, which was lower
than the sensitivity and specificity of ≥95% recom-
mended by WHO [12], deployment of RDTs in the
longitudinal study reduced anti-malarial dispensing by
CORPs from 99% in the pre-RDT to 32% (among cases
aged ≥5 years of age) in the post-RDT period. Similar
studies conducted in other parts of Tanzania have
recently shown that correct use of RDTs and adherence
to test results by health workers reduced dispensing of
anti-malarial drugs by > 60% [44]. Furthermore, majority
of the cases treated with ALu during the post-RDTs
period were confirmed to have malaria parasites by
microscopy since only 28.6% of the cases treated had
negative results by microscopy while during the pre-
RDTs, 78.5% of the cases treated with SP had negative
results.
Adherence to treatment guidelines by CORPs as stipu-
lated in the SOPs was high (> 95%) in cases of all age
groups. The level of adherence to treatment guidelines
shown in this study was higher than what was reported
by previous studies conducted in Zanzibar [45] and Bur-
kina Faso [42,46] possibly due to the training provided
to CORPs and weekly supportive supervision conducted
by an experienced team. However, some cases con-
firmed to have malaria by microscopy (during both peri-
ods) were not treated with anti-malarials and were also
not referred to the nearest health facilities for further
treatment as required by the guidelines. These were
relatively few (< 0.5%) and could possibly return to
CORPs for treatment in case their medical conditions
worsened because the services were readily available
within their communities. The level and consistency of
supervision has been shown to influence the proper
implementation of RDTs and adherence to test results
by service providers under routine health facility settings
[21,32]. However, such level of supervision can hardly be
provided and maintained by the health authorities when
RDTs are implemented and widely used under routine
clinical settings. Thus, during deployment of RDTs,
health authorities will need to design and implement a
sustainable scheme of supportive supervision (relevant
to their local settings) to ensure the accuracy of RDTs is
maintained and service providers adherence to National
treatment policy and guidelines. Such strategies will also
help to maintain health workers confidence on RDT
results, reduce the need for syndromic treatment and
target management of other causes of fevers in non-
malaria cases.
The current study utilized two brands of HRP-2 based
RDTs (Paracheck and ParaHIT) which showed variable
results regarding their accuracy, whereby both brands
had similar sensitivity in the longitudinal study while
Paracheck showed higher sensitivity in the CSS. In both
studies, ParaHIT had higher specificity compared to
Paracheck. Although these differences could be a true
reflection of their performance under field conditions in
an area where malaria has remarkably declined [28], this
study was not designed to address such question. The
tests were used based on their availability from the
NMCP and thus the study did not make any attempt to
compare their performance.
Furthermore, the performance of RDTs was compared
to expert microscopy whose quality cannot be attained
under health facility settings as recently shown by stu-
dies conducted in Tanzania [8] and other malaria ende-
mic areas [38]. The tests were also used for parasite
detection in CSS in order to identify cases that were tar-
geted for in-vivo efficacy study of anti-malarials and in-
vitro monitoring of drug resistance (which were stopped
due to lack of enough samples). Unlike in health facil-
ities and community studies where febrile patients are
commonly attended and RDTs are intended to detect
patients with parasites, the tests cannot be similarly
used in CSS due to low number of patients with fever,
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shown by the findings of the CSS. However, these find-
ings provide important information which will poten-
tially guide future applicability of RDTs when fully
introduced in many endemic countries for malaria diag-
nosis in the health facilities and communities; emphasiz-
ing that the tests have more relevance for case
management than for disease surveillance.
In the longitudinal study, some cases with malaria
parasites (confirmed by microscopy) were neither trea-
ted with anti-malarials (SP or ALu during the pre-RDT
and post-RDT periods, respectively) nor given a referral
to be attended at nearby health facilities as stipulated in
the guidelines given to CORPs. While it would intui-
tively be important to know what happened to such
cases, these issues are beyond the scope of this study
since only passive case detection of fever episodes was
performed, and follow-up of cases after treatment or
those with negative RDT results who were not given
anti-malarials was not done. However, other studies
conducted in northern Tanzania showed that only 1% of
children with negative RDT results developed parasitae-
mia during the 28 days of follow-up and only 1 out of
816 children developed a severe malaria condition
demanding hospitalisation (Reyburn et al. personal com-
munication). Based on the setting of the longitudinal
study where medical services were made available in the
community through CORPs, cases not given anti-malar-
ials had an opportunity to get treatment whenever they
felt unwell, thus making this strategy safe and rational
for testing the implementation of malaria case manage-
ment based on RDT results.
Conclusion
This study showed that RDTs used in the two commu-
nity studies had varying accuracy (low sensitivity but
relatively higher specificity) indicating that diagnosis of
malaria using these HRP-2 based RDTs particularly in
this era of declining burden of malaria remains a pro-
blem. Patients presenting in the health facilities from
these communities for diagnosis of malaria are likely to
have low parasite density which the current tests may
fail to detect due to low sensitivity. High specificity of
the RDTs indicates that most of the patients without
malaria were correctly detected. However, introduction
of RDTs in the longitudinal study reduced the number
of cases without malaria who were treated with antima-
larial drugs during the pre-RDTs as compared to the
post-RDT period. Therefore, deployment of RDTs,
coupled with supportive supervision can potentially
reduce over-treatment and provide an opportunity for
improved malaria diagnosis, and proper management of
both malaria and non-malaria fevers. However, contin-
ued search and eventually introducing other alternative
and sensitive malaria diagnostic methods should be
explored.
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